Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05007834

Metabolism, Circadian Rhythms and Ovarian Function

Impact of Metabolic Status and Circadian Rhythms on Post-chemotherapy Ovarian Recovery in Women Treated for Breast Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
Female
Age
25 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Chemotherapy for cancer, due to its gonadotoxicity, can lead to impaired female fertility, resulting in the occurrence of transient or prolonged chemo-induced amenorrhea (CIA). According to recent data from the National Cancer Institute, 11.9% of women under the age of 40 diagnosed with cancer have been offered a fertility evaluation within five years of diagnosis. Predicting the risk and especially the duration of the CIA remains difficult. Known factors predicting a rapid return of menstruation are a young age at diagnosis, a low gonadotoxic treatment (absence of alkylating agents) and a high pre-chemotherapy blood level of AMH reflecting a large pool of growing follicles. A body mass index (BMI) ≥ 25 kg / m² could also be a positive predictor, but this remains debated. The objective of this project is to assess the impact of metabolism and energy reserves, physical activity and the chronotype on the recovery of ovarian function in patients with breast cancer who have developed CIA

Conditions

Timeline

Start date
2022-02-24
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2021-08-16
Last updated
2025-12-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05007834. Inclusion in this directory is not an endorsement.